600 mg per vial lets a provider adjust up or down based on labs and tolerance
Mu H, MD, PhD, Konopleva M, MD, PhD, Jacamo R, PhD, Carter BZ, PhD, McQueen T, MS, Andreeff M , MD, PhD
Regular follow-up appointments will be scheduled to monitor your progress and adjust your treatment plan as needed
There is one open-label intravenous safety pilot in two healthy adults, who received single doses of 10 mg and 20 mg with no comparator, no blinding, and short-term observation limited to vital signs, self reported symptoms and labs across two days [4]